Axsome Therapeutics Inc

NASDAQ:AXSM   3:59:52 PM EDT
33.44
+0.48 (+1.46%)
4:56:04 PM EDT: $33.35 -0.09 (-0.27%)
Products, Regulatory

Axsome Therapeutics Provides Update On The New Drug Application For Axs-05 For The Treatment Of Major Depressive Disorder

Published: 08/23/2021 12:47 GMT
Axsome Therapeutics Inc (AXSM) - Axsome Therapeutics Provides Update on the New Drug Application for Axs-05 for the Treatment of Major Depressive Disorder.
Axsome - Review of NDA for Axs-05 for Treatment of Major Depressive Disorder Would Not Be Completed by PDUFA Target Action Date of Aug 22, 2021.
Axsome Therapeutics - FDA Did Not Request Additional Information From Co, and Review of Application is Ongoing.